MARCH 3: “Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Africa, today announced it had secured investment of up to $43 million from Malin Corporation plc, an Ireland-based global life sciences company focused on healthcare.” A historic Series A round.
https://lnkd.in/e2Vi8Ce
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022